Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.72 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.66 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.59 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.59 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.59 |
| ▸ | TUBB | P07437 | 1/20 | 0.59 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.59 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.59 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.59 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.59 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.59 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.59 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.59 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.59 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.59 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3,4-Dimethoxy Cinnamaldehyde SCHEMBL3000359 | 1.00 | XDH (0.72) | XDHTRPA1MTNR1AALDH1A1TSHR | |
| SCHEMBL1426730 | 0.93 | XDH (0.63) | XDHTRPA1MTNR1AALDH1A1TSHR | |
| SCHEMBL1426731 | 0.93 | XDH (0.63) | XDHTRPA1MTNR1AALDH1A1TSHR | |
| SCHEMBL6966726 | 0.87 | XDH (0.60) | XDHTRPA1MTNR1AALDH1A1TSHR | |
| SCHEMBL11869754 | 0.87 | TRPA1 (0.68) | XDHTRPA1MTNR1AALDH1A1TSHR | |
| SCHEMBL11869759 | 0.87 | TRPA1 (0.68) | XDHTRPA1MTNR1AALDH1A1TSHR | |
| SCHEMBL6966722 | 0.87 | XDH (0.60) | XDHTRPA1MTNR1AALDH1A1TSHR | |
| SCHEMBL3241265 | 0.85 | JUN (0.71) | XDHTRPA1MTNR1AALDH1A1TSHR | |
| SCHEMBL9329884 | 0.85 | TRPA1 (0.67) | XDHTRPA1MTNR1AALDH1A1TSHR | |
| SCHEMBL29414983 | 0.85 | JUN (0.71) | XDHTRPA1MTNR1AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11781061-B2 | Corrosion protection method for wellbore piping | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-10-10 | — | — | US | claimed |
| CN-115322182-A | Azole antifungal compound and application thereof | 广西医科大学 | 2022-11-11 | — | — | CN | claimed |
| CN-108299458-B | Oridonin derivative and preparation method and application thereof | 青岛海洋生物医药研究院股份有限公司 | 2020-10-02 | — | — | CN | claimed |
| CN-103896958-A | Oridonin and use of ent-6,7-open-loop kaurene type derivative thereof in preparing antituberculosis medicaments | UNIV CHINA PHARMA | 2014-07-02 | — | — | CN | claimed |
| US-20100292158-A1 | Compositions and Methods for Enhanced Pharmacological Activity of Compositions Comprising Peptide Drug Substances | IMMUPHARMA SA (FRANCE) | 2010-11-18 | — | — | US | claimed |
| US-7671029-B2 | Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances | IMMUPHARMA SA (FR) | 2010-03-02 | — | — | US | claimed |
| US-20040186058-A1 | Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances | UREKA SARL (FR) | 2004-09-23 | — | — | US | claimed |
| US-6566557-B2 | Oxidation of a phenylpropane compound | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-05-20 | — | — | US | claimed |
| US-20020133045-A1 | Process for the preparation of substituted trans-cinnamaldehyde, a natural yellow dye, from phenylpropane derivatives | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-09-19 | — | — | US | claimed |
| WO-2002072709-A1 | A PROCESS FOR THE PREPARATION OF SUBSTITUTED TRANS-CINNAMALDEHYDE, A NATURAL YELLOW DYE, FROM PHENYLPROPANE DERIVATIVES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-09-19 | — | — | WO | claimed |
| US-6241995-B1 | VACCINE TO ENHANCE IMMUNE RESPONSE | UNIVERSITY OF SASKATCHEWAN (CA) | 2001-06-05 | — | — | US | claimed |
| CN-1211182-A | Neovascularization inhibitor | KISSEI PHARMACEUTICAL (JP) | 1999-03-17 | — | — | CN | claimed |
| EP-0446047-B1 | Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors | UNILEVER PLC (GB) | 1997-06-11 | — | — | EP | claimed |
| EP-0446047-A1 | Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors | UNILEVER PLC (GB) | 1991-09-11 | — | — | EP | claimed |
| US-4402981-A | ANTIULCER AGENT | KALI-CHEMIE PHARMA, GMBH (DE) | 1983-09-06 | — | — | US | claimed |
| US-4369309-A | HYPOTENSIVE AGENTS; UASODILATION; CARDIOVASCULAR DISORDERS | SS PHARMACEUTICAL CO., LTD. (JP) | 1983-01-18 | — | — | US | claimed |
| JP-58008046-A | — | — | None | — | — | JP | disclosed |
| JP-9217052-A | — | — | None | — | — | JP | disclosed |
| US-3973030-A | Antiasthmatic 5,6-benzoisoindoline compositions | CIBA-GEIGY CORPORATION (US) | 1976-08-03 | — | — | US | disclosed |
| US-3957823-A | METALLIZATION | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020133045-A1 | Process for the preparation of substituted trans-cinnamaldehyde, a natural yellow dye, from phenylpropane derivatives | CBR3, DDT, DHODH | XDH 663/4885TRPA1 630/4885MTNR1A 4331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.